Domain Therapeutics
2 known investors
Domain Therapeutics develops drug discovery and development therapies that target GPCRs to modulate the immune system, focusing on immuno-oncology and inflammatory diseases.
2 known investors
Domain Therapeutics develops drug discovery and development therapies that target GPCRs to modulate the immune system, focusing on immuno-oncology and inflammatory diseases.